-
Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.
Wright D, Syngelaki A, Staboulidou I, Cruz JJ, Nicolaides KH.
Prenat Diagn 2011;31:16-21. -
First-trimester markers of aneuploidy in women positive for HIV.
Savvidou M, Samuel I, Syngelaki A, Poulton M, Nicolaides K.
BJOG 2011;118:844-8. -
First-trimester prediction of macrosomia.
Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011;29:139-47. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling.
Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH.
Prenat Diagn 2011;31:38-45. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3. -
Repeatability of measurement of fetal nuchal translucency thickness.
Pandya PP, Brizot ML, Altman D, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:334-7. -
The implementation of first trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:20-5. -
Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:15-9. -
Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses.
Pandya PP, Hilbert F, Snijders RJM, Nicolaides KH.
J Ultrasound Med 1995;14:565-8. -
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP, Snijders RJ, Johnson SP, Brizot ML, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:957-62. -
Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
Noble PL, Abraha HD, Snijders RJ, Sherwood R, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:390-5. -
Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome.
Hyett JA, Clayton PT, Moscoso G, Nicolaides KH.
Am J Med Genet 1995;58:374-6. -
First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
Hyett JA, Moscoso G, Nicolaides KH.
Am J Obstet Gynecol 1995;172:1411-3. -
Cardiac defects in 1st-trimester fetuses with trisomy 18.
Hyett JA, Moscoso G, Nicolaides KH.
Fetal Diagn Ther 1995;10:381-6. -
Increased nuchal translucency in Trisomy 21 fetuses: Relation to narrowing of the aortic isthmus.
Hyett JA, Moscoso G, Nicolaides KH.
Hum Reprod 1995;10:3049-3051. -
Morphometric analysis of the great vessels in early fetal life.
Hyett JA, Moscoso G, Nicolaides KH.
Hum Reprod 1995;10:3045-8. -
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML, Snijders RJ, Butler J, Bersinger NA, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:127-32.